GGrantIndex
Sort

78,016 grants matching breast cancer

Intratumor heterogeneity underlying treatment resistance in HER2+ breast tumors

$671,607
Kornelia Polyak · Dana-Farber Cancer Inst · U01 · FY2018 · CA

Affinity-Based Serum Proteomics: Breast and Ovarian Can*

$671,600
Martin W McIntosh · Fred Hutchinson Cancer Research Center · U01 · FY2006 · CA

Optoacoustic imaging enhanced by gold nanorods

$671,583
Alexander A Oraevsky · Fairway Medical Technologies, Inc. · R44 · FY2006 · CA

Prevention of Osteoporosis in Breast Cancer Survivors

$671,547
University Of Nebraska Medical Center · R01 · FY2003 · NR

Evaluation of novel tomosynthesis density measures in breast cancer risk prediction

$671,511
Celine M Vachon · Mayo Clinic Rochester · R01 · FY2025 · CA

Identification of Genes and DNA Methylation Markers for Lung Cancer Risk by Integrating Multi-omics Data

$671,454
Qiuyin Cai · Vanderbilt University Medical Center · R01 · FY2025 · CA

Spectro-Holographic Instrument for Dynamic Sensing of Cancer Progression

$671,429
Lev T. Perelman · Beth Israel Deaconess Medical Center · R01 · FY2019 · CA

Molecular mechanism of Na+ -coupled HCO3- transporters: transport of CO3= and CO2

$671,400
Walter F Boron · Case Western Reserve University · R01 · FY2023 · DK

Promoting Breast Cancer Screening in Non-Adherent Women

$671,363
Roger S Luckmann · Univ Of Massachusetts Med Sch Worcester · R01 · FY2010 · CA

ATLANTA REGIONAL COMMUNITY CLINICAL ONCOLOGY PROGRAM

$671,359
St. Joseph'S Hospital · U10 · FY2002 · CA

Role of ABCG2 in the disposition and anti-hyperuricemic effects of allopurinol

$671,330
Kathleen M Giacomini · University Of California, San Francisco · R01 · FY2015 · DK

EXERCISE, DIET, AND SEX HORMONES IN POSTMENOPAUSAL WOMEN

$671,321
Anne M McTiernan · Fred Hutchinson Cancer Research Center · R01 · FY2006 · CA

FINDING THE M.I.N.C. FOR MAMMOGRAPHY MAINTENANCE

$671,304
University Of North Carolina Chapel Hill · R01 · FY2003 · CA

Biomaterials (Mf/Zn/F-BCPs) for osteoporosis therapy

$671,230
Racquel Z Legeros · New York University · R01 · FY2010 · AR

Minnesota Community Networks Center For Eliminating Cancer Disparaties

$671,190
Kolawole S Okuyemi · University Of Minnesota · U54 · FY2013 · CA

Development of high throughput screening technologies in breast cancer

$671,169
Konstantinos Konstantopoulos · Johns Hopkins University · R01 · FY2015 · CA

Serum biomarkers to predict immune related adverse events and benefit from single agent pembrolizumab therapy in early stage triple negative breast cancer

$671,146
Ji Qiu · Arizona State University-Tempe Campus · R01 · FY2024 · CA

Genetic Susceptibility And The Environment In Cancer Risk

$671,063
Jack A Taylor · National Institute Of Environmental Health Sciences · ZIA · FY2018 · ES

Understanding the role of adiposity and adipokine-related RNA expression in the tumor microenvironment on breast cancer outcomes in a racially and ethnically diverse sample

$671,015
Adana A. M. Llanos · Columbia University Health Sciences · R01 · FY2024 · CA

Breast Cancer Brain Metastasis Therapy by Focused Ultrasound-Guided Control of HER2 CAR T cells

$670,977
Konstantinos-Costas Arvanitis · Georgia Institute Of Technology · R01 · FY2025 · CA

Dynamics of Gene and Isoform Regulation during EMT and tumor progression

$670,868
Frank B Gertler · Massachusetts Institute Of Technology · U01 · FY2017 · CA

Development of Non-Catalytic Peptide Inhibitors of Focal Adhesion Kinase (FAK) for Use in Melanoma

$670,756
Timothy A Marlowe · Faknostics, Llc · R42 · FY2022 · CA

Steady states and cellular transitions associated with carcinogenesis and tumorprogression

$670,711
James R. Heath · Institute For Systems Biology · U01 · FY2021 · CA

Statistical Informatics for Cancer Research

$670,689
Xihong Lin · Harvard School Of Public Health · P01 · FY2015 · CA

Kalamazoo Community Clinical Oncology Program

$670,631
Raymond S Lord · West Michigan Cancer Center · U10 · FY2008 · CA